Guardian Pharmacy Services Inc.
GRDN | NYSE
$45.15
+$0.99 (+2.24%)
Sep 22, 2026, 2:33 PM ET · Market open
Market Data
Market Cap $2.8B
Enterprise Value $2.71B
Beta 0.10
Average Volume 402.12K
Shares Outstanding (Diluted) 63.84M
Shares Change YoY 1%
Institutional Ownership 44.72%
Exchange NYSE
ISIN US40145W1018
Price Performance
Price Change 1M 16.4%
Price Change 3M 12.7%
Price Change 6M 21.0%
Price Change YTD 49.5%
Price Change 1Y 74.2%
Price Change 3Y 148.8%
Price Change 5Y 148.8%
1M CAGR (ann.) 0.8%
1Y CAGR (ann.) 67.2%
5Y CAGR (ann.) N/A
All-Time CAGR 66.7%
Valuation
PE Ratio 42.87
Forward PE 30.68
PEG Ratio 0.15
Forward PEG 4.33
PS Ratio 1.91
Forward PS 1.80
PB Ratio 10.85
P/FCF Ratio 34.59
P/Adj. FCF Ratio 40.68
P/OCF Ratio 28.31
EV/Sales 1.85
EV/EBIT 28.14
EV/EBITDA 23.81
EV/FCF 33.58
Earnings Yield 2.3%
FCF Yield 2.9%
Adj. FCF Yield 2.5%
Financial Health
Net Cash $82.43M
Total Debt $7.38M
Cash & Short-Term Investments $89.81M
Total Assets $443.58M
Current Ratio 1.65
Quick Ratio 1.33
Debt / Equity Ratio 0.14
Debt / EBITDA 0.06
Debt / FCF 0.09
OCF / Debt 14.23
Interest Coverage 145.39
Altman Z-Score 13.63
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 21.6%
Operating Profit Margin 6.3%
EBITDA Margin 7.8%
Net Profit Margin 4.5%
FCF Margin 5.5%
Adj. FCF Margin 4.7%
SBC / Revenue 0.7%
SBC Impact (per share) -15.0%
Returns
Return on Assets 14.9%
Return on Equity 30.8%
Return on Invested Capital 21.4%
Return on Capital Employed 31.7%
Return on Tangible Assets 19.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 14.4%
Revenue CAGR 5Y 21.6%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 10.7%
EPS CAGR 5Y 56.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 21.2%
FCF CAGR 5Y 32.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) $0.32
EPS Growth Est (next Q) 28.0%
Revenue Est (next Q) $365.84M
Revenue Growth Est (next Q) -3.1%
Fair Value Estimates
Graham Number $9.71
Graham Upside -78.0%
Lynch Fair Value $25.75
Lynch Upside -41.7%
Price Target $50
Price Target Upside 13.2%
Cash Flow
Operating Cash Flow $104.92M
Free Cash Flow $80.83M
Adj. Free Cash Flow $68.74M
FCF Per Share $1.26
OCF Per Share $1.56
OCF/S Ratio 6.8%
Income Statement
Revenue $1.46B
Gross Profit $316.58M
Operating Income $91.74M
EBITDA $114M
Net Income $65.91M
EPS (Diluted) $1.03
Revenue / Employee $406.5K
Profit / Employee $18.31K
Employees 3,600
Add to Watchlist
Select watchlists to add or remove GRDN